Psychotherapeutic and pharmacological agents for post-traumatic stress disorder with sleep disorder: network meta-analysis

Ann Med. 2024 Dec;56(1):2381696. doi: 10.1080/07853890.2024.2381696. Epub 2024 Jul 26.

Abstract

Objective: The current guidelines and canonical norms of diagnosis or treatment for Post-traumatic stress disorder (PTSD) with sleep disorder are still conflicting and have not yet reached a consensus. This study aimed to unravel the most effective countermeasures between two categories (psychotherapy and pharmacotherapy) put forward by the National Institute for Health and Clinical Excellence (NICE) and World Federation of Societies of Biological Psychiatry (WFSBP) respectively to treat PTSD individuals co-exist with sleep disorders.

Methods: Four databases, including PubMed, EMBASE, Cochrane Library, and APA PsyNet, were searched from inception to February 02, 2023.

Results: Twenty articles with 24 Randomized controlled trials (RCTs) and a total number of 1,647 participants were included. As demonstrated in the network meta-analysis comparison results, CBT-I (standardized mean differences (SMD) = -1.51,95% confidence interval (CI):-2.55 to -0.47), CBT-I plus IRT (SMD = -1.71, 95%CI:-3.39, -0.03), prazosin (SMD = -0.87,95%CI:-1.59 to -0.16) and hydroxyzine (SMD = -1.06, 95%CI: -1.94 to -0.19) significantly reduced PTSD symptoms compared with placebo. In contrast to placebo, CBT-I (SMD = -5.61,95%CI:-8.82 to -2.40) significantly improved sleep quality. For nightmare severity, IRT (SMD =-0.65, 95%CI:-1.00 to -0.31), prazosin (SMD = -1.20,95%CI:-1.72 to -0.67) and hydroxyzine (SMD = -0.98,95%CI:-1.58 to -0.37) significantly reduced nightmare severity in comparison with placebo.

Conclusions: This study suggested that under most circumstances, psychotherapy namely CBT-I had a favorable profile, but pharmacotherapy with prazosin was effective in managing nightmare severity. The sole avail of CBT-I was recommended to improving sleep quality while CBT-I and CBT-I plus IRT showed excellent management of PTSD symptom severity. Exposure to CBT-I isrecommended for depression. The relevant clinical guidelines for the management of individuals with PTSD and sleep disorders may regard this as a reference.

Prospero: CRD42023415240.

Keywords: Post-traumatic stress disorder; cognitive behavioral therapy for insomnia; pharmacotherapy; prazosin; psychotherapy; sleep disorders.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Adult
  • Cognitive Behavioral Therapy / methods
  • Eye Movement Desensitization Reprocessing / methods
  • Female
  • Humans
  • Hydroxyzine / therapeutic use
  • Male
  • Network Meta-Analysis*
  • Prazosin* / therapeutic use
  • Psychotherapy / methods
  • Randomized Controlled Trials as Topic*
  • Sleep Wake Disorders* / drug therapy
  • Sleep Wake Disorders* / therapy
  • Stress Disorders, Post-Traumatic* / drug therapy
  • Stress Disorders, Post-Traumatic* / therapy
  • Treatment Outcome

Substances

  • Prazosin
  • Hydroxyzine

Grants and funding

No specific funding was received for this study.